Palisade Bio (PALI) Change in Receivables (2011 - 2023)
Palisade Bio's (PALI) quarterly Change in Receivables came in at $250000.0 in Q1 2023, up 523.73% on a QoQ basis from -$59000.0 in Q3 2021.
Palisade Bio (PALI) Change in Receivables (2011 - 2023) Analysis & Trends
Palisade Bio (PALI) has 12 years of Change in Receivables data on file, last reported at $250000.0 in Q1 2023.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to $250000.0 in Q1 2023; TTM through Mar 2024 was $250000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at -$84000.0, down 242.37% from the prior year.
- Change in Receivables for Q1 2023 stood at $250000.0, up from -$59000.0 in the prior quarter.
- Over the last five years, Change in Receivables for PALI reached as high as $250000.0 in Q1 2023 and fell as low as -$108751.0 in Q3 2019.
- Historically, Change in Receivables has averaged -$4363.0 across 4 years, with a median of -$40090.0 in 2019.
- Across the five-year window, Change in Receivables jumped 181.1% in 2020 and tumbled 2778.05% in 2021, its largest moves.
- Year by year, Change in Receivables stood at -$40090.0 in 2019, then surged by 114.97% to $6000.0 in 2020, then slumped by 1083.33% to -$59000.0 in 2021, then soared by 523.73% to $250000.0 in 2023.
- Per Business Quant data, the three most recent Change in Receivables figures were $250000.0 in Q1 2023, -$59000.0 in Q3 2021, and $34000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Jun 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 34,000.00 |
| Mar 31, 2021 | -59,000.00 |
| Mar 31, 2021 | -59,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Jun 30, 2020 | 55,050.00 |
| Jun 30, 2020 | 55,050.00 |
| Mar 31, 2020 | -2,050.00 |
| Mar 31, 2020 | -2,050.00 |
| Dec 31, 2019 | -40,090.00 |
| Dec 31, 2019 | -40,090.00 |
| Sep 30, 2019 | -108,751.00 |
| Sep 30, 2019 | -108,751.00 |
| Jun 30, 2019 | -67,877.00 |
| Jun 30, 2019 | -67,877.00 |